Compare Hims and Hers Health Inc (HIMS) vs Carparts.Com Inc (PRTS) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

PRTS trades at $4.97, down 6.23% today, following a 10:1 reverse stock split effective May 26, 2026, which helped it regain Nasdaq compliance. The company reported a Q1 2026 adjusted EBITDA beat and secured a $25 million credit facility in June 2026. Revenue has declined from $676M in 2023 to $548M in 2025, with net losses widening to -$50M. Analyst sentiment is positive with 60% buy ratings, but negative cash flow and profitability metrics highlight operational challenges.

The outlook remains cautious due to persistent losses and revenue contraction, though cost-cutting and new financing provide some stability. Investment opportunity lies in potential turnaround execution and low P/S of 0.06, but risks include cash burn, competitive pressures, and reliance on external funding. Investors should weigh analyst optimism against fundamental weaknesses before considering a position.